Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Talkhoncheh MS"'
Autor:
Talkhoncheh MS; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Baudet A; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Ek F; Chemical Biology and Therapeutics, Department of Experimental Medical Science, Lund University, Lund, Sweden., Subramaniam A; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Kao YR; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY., Miharada N; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Karlsson C; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Oburoglu L; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Rydström A; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Zemaitis K; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Alattar AG; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Rak J; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Pietras K; Division of Translational Cancer Research, Medicon Village, Lund University, Lund, Sweden., Olsson R; Chemical Biology and Therapeutics, Department of Experimental Medical Science, Lund University, Lund, Sweden., Will B; Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY.; Department of Medicine (Oncology), Albert Einstein College of Medicine, Bronx, NY., Larsson J; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden.
Publikováno v:
Blood advances [Blood Adv] 2023 Dec 26; Vol. 7 (24), pp. 7407-7417.
Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171.
Autor:
Subramaniam A; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Žemaitis K; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Talkhoncheh MS; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Yudovich D; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Bäckström A; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Debnath S; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Chen J; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Jain MV; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Galeev R; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Gaetani M; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; and.; SciLifeLab, Stockholm, Sweden., Zubarev RA; Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden; and.; SciLifeLab, Stockholm, Sweden., Larsson J; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden.
Publikováno v:
Blood [Blood] 2020 Nov 05; Vol. 136 (19), pp. 2151-2161.
Autor:
Chapellier M; Department of Clinical Genetics., Peña-Martínez P; Department of Clinical Genetics., Ramakrishnan R; Department of Clinical Genetics., Eriksson M; Department of Clinical Genetics., Talkhoncheh MS; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Orsmark-Pietras C; Department of Clinical Genetics., Lilljebjörn H; Department of Clinical Genetics., Högberg C; Department of Clinical Genetics., Hagström-Andersson A; Department of Clinical Genetics., Fioretos T; Department of Clinical Genetics., Larsson J; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Järås M; Department of Clinical Genetics marcus.jaras@med.lu.se.
Publikováno v:
Haematologica [Haematologica] 2019 Oct; Vol. 104 (10), pp. 2006-2016. Date of Electronic Publication: 2019 Feb 28.
Autor:
Kumar P; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Beck D; Adult Cancer Program, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia.; Centre for Health Technologies and.; School of Software, University of Technology Sydney, Sydney, NSW, Australia; and., Galeev R; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Thoms JAI; Adult Cancer Program, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia., Talkhoncheh MS; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., de Jong I; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Unnikrishnan A; Adult Cancer Program, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia., Baudet A; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Subramaniam A; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Pimanda JE; Adult Cancer Program, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales Sydney, Sydney, NSW, Australia.; Department of Haematology, Prince of Wales Hospital, Sydney, NSW, Australia., Larsson J; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden.
Publikováno v:
Blood advances [Blood Adv] 2019 Feb 26; Vol. 3 (4), pp. 681-691.
Autor:
Subramaniam A; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Talkhoncheh MS; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Magnusson M; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Larsson J; Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden jonas.larsson@med.lu.se.
Publikováno v:
Haematologica [Haematologica] 2019 Feb; Vol. 104 (2), pp. e47-e50. Date of Electronic Publication: 2018 Jul 19.
Autor:
Talkhoncheh MS; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Subramaniam A; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Magnusson M; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Kumar P; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden., Larsson J; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden jonas.larsson@med.lu.se., Baudet A; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Sweden.
Publikováno v:
Haematologica [Haematologica] 2018 Sep; Vol. 103 (9), pp. 1444-1450. Date of Electronic Publication: 2018 Jun 07.
Autor:
Svalgaard JD; 1 Department of Clinical Immunology, Cell Therapy Facility, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Talkhoncheh MS; 2 Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Haastrup EK; 1 Department of Clinical Immunology, Cell Therapy Facility, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Munthe-Fog L; 1 Department of Clinical Immunology, Cell Therapy Facility, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Clausen C; 3 Bioneer A/S, Hoersholm, Denmark., Hansen MB; 1 Department of Clinical Immunology, Cell Therapy Facility, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Andersen P; 4 Department of Clinical Immunology, Stem Cell Facility, Herlev Hospital, Herlev, Denmark., Gørløv JS; 5 Department of Hematology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark., Larsson J; 2 Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Fischer-Nielsen A; 1 Department of Clinical Immunology, Cell Therapy Facility, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
Publikováno v:
Cell transplantation [Cell Transplant] 2018 Sep; Vol. 27 (9), pp. 1407-1412. Date of Electronic Publication: 2018 Jul 30.
Autor:
Rak J; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Foster K; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom; and., Potrzebowska K; Division of Immunology and., Talkhoncheh MS; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Miharada N; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Komorowska K; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden., Torngren T; Division of Oncology and Pathology, Lund University, Lund, Sweden., Kvist A; Division of Oncology and Pathology, Lund University, Lund, Sweden., Borg Å; Division of Oncology and Pathology, Lund University, Lund, Sweden., Svensson L; Division of Immunology and., Bonnet D; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, United Kingdom; and., Larsson J; Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Center, Lund University, Lund, Sweden.
Publikováno v:
Blood [Blood] 2017 Feb 23; Vol. 129 (8), pp. 950-958. Date of Electronic Publication: 2016 Nov 29.